Suzhou Layuan Pharmaceutical Chemistry Technology Co., Ltd. becomes a long-term strategic partner
Guangzhou Huajing International Trade Co., Ltd. and Suzhou Lai'an Pharmaceutical Chemistry Technology Co., Ltd. officially established a long-term strategic partnership on 2026/4/25. The two companies will collaborate deeply in the fields of pharmaceutical intermediates and fine chemicals to serve global customers together.
Suzhou Layan Pharmaceutical Chemistry Technology Co., Ltd. is a leading domestic enterprise specializing in the research, development, production, and sales of pharmaceutical intermediates and fine chemical products. With advanced synthesis technologies and a rigorous quality management system, our products are widely used in anti-cancer, antiviral, and cardiovascular drugs, and are exported to over 30 countries and regions worldwide.
This partnership is driven by the growing global demand for high-quality pharmaceutical intermediates and fine chemical products. As innovation in drug development accelerates and the generic drug market expands rapidly, pharmaceutical companies worldwide are raising their standards for quality, purity, and stability. Qingyuan Huajing International Trade Co., Ltd. leverages its global sales network and expert supply chain capabilities to create a complementary synergy with Lai'an Pharmaceutical.
Per the agreement, Layan Pharma will serve as the core supplier for Qingyuan Huajing International Trade Co., Ltd., ensuring priority product supply and consistent quality. The two parties will deepen their collaboration in the following areas: 1. Product Supply: Layan Pharma will provide stable, high-quality pharmaceutical intermediates and fine chemical products to Qingyuan Huajing International Trade Co., Ltd. 2. Market Expansion: Both parties will jointly develop emerging markets in Southeast Asia, the Middle East, and Europe, sharing market insights and customer resources. 3. Technical Exchange: Layan Pharma will offer technical support and application guidance for its products to Qingyuan Huajing International Trade Co., Ltd., helping customers optimize product usage.
The General Manager of Qingyuan Huajing International Trade Co., Ltd. stated: "Lian Pharmaceutical is a key strategic partner. Over the years, Lian Pharmaceutical has provided us with high-quality pharmaceutical intermediates and fine chemical products, earning the trust of our global pharmaceutical clients. By establishing this long-term strategic partnership, we will further integrate both parties' strengths to expand into international markets together and achieve mutual benefit."
The head of Lian'an Pharma stated: "Qingyuan Huajing International Trade Co., Ltd. possesses extensive international client resources and professional service capabilities. Through this partnership, our pharmaceutical intermediates and fine chemical products will better reach global markets and serve pharmaceutical customers worldwide. We will continue to enhance product quality and production capacity to provide stronger support to our partners."
This collaboration also includes joint participation in international exhibitions, co-development of new products, and establishment of a regular communication mechanism. Both parties plan to jointly attend the European Pharmaceutical Ingredients Exhibition and the US Pharmaceutical Exhibition in the second half of 2026 to showcase their collaborative achievements and latest products.
Industry analysts note that this partnership aligns with the broader trend of resource integration and collaborative growth in the pharmaceutical and fine chemicals sectors. As the global pharmaceutical industry continues to expand, demand for high-quality pharmaceutical intermediates and fine chemical products is expected to rise. This collaboration is poised to deliver significant commercial value to both parties while jointly advancing the development of the global pharmaceutical sector.
